Wikidata

(Q74274773)

English

Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Phase Ib, Open-label, Randomized Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - First-MIND (English)
0 references
country
Austria
0 references
Belgium
0 references
Germany
0 references
Portugal
0 references
start time
November 2019
0 references
end time
November 2020
0 references
number of participants
60
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q74274773&oldid=1859018679"